A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 in Subjects with Advanced Solid Tumors

  • Gurney, Howard (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Butala, Radhika (Clinical Trial Unit Staff)
  • Parshionikar, Abhijit (Clinical Trial Unit Staff)
  • Rajasekharan Nair, Archana (Clinical Trial Unit Staff)

Project: Other

Project Details

Short titleProtocol 4003.1
AcronymHarbour Biomed 4003.1
StatusFinished
Effective start/end date30/09/19 → 30/09/24